Floatz logo

Alpha Tocopherol

Depressive Disorder, Major

UConn HealthmixturePhase 2/3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the Depressive Disorder, Major cohort.

Asset / SponsorPhaseRating
Amitriptyline
Janssen Research & Development, LLC
Phase 4BBB
S-Ketamine
Janssen Research & Development, LLC
Phase 4BBB
Pregabalin
Janssen Research & Development, LLC
Phase 4BBB
Seroquel®
Janssen Research & Development, LLC
Phase 4BBB
((3AR,6AS)-5-(4,6-DIMETHYLPYRIMIDIN- 2-YL)HEXAHYDROPYRROLO(3,4-C)PYRROL-2(1H)-YL)(2-FLUORO- 6-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE OREXIN RECEPTOR ANTAGONIST
Janssen Research & Development, LLC
Phase 3BB

View all 50 →

Same molecule, other indications

Alpha Tocopherol is also rated in:

metabolic dysfunction-associated steatohepatitisDormant
BBB
Indicative ·
73 / 100
View asset →
fatty liver diseaseDormant
BB
Indicative ·
70 / 100
View asset →
ProdromeDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →